A revolutionary malaria treatment is to begin trials in Mozambique in healthy people. Along with their standard WHO vaccinations, 2000 newborn infants—and 600 pregnant women—will be given the anti-malarial drug sulfadoxine-pyrimethamine. In a smaller trial in Tanzania, the preventative treatment reduced the rate of clinical malaria by almost 60 per cent, and halved the rate of severe anaemia caused by malaria. Researchers from the Hospital Clinic of Barcelona now hope to confirm these findings.
To continue reading, today with our introductory offers
Advertisement
More from Â鶹´«Ã½
Explore the latest news, articles and features
Popular articles
Trending Â鶹´«Ã½ articles
1
Why the right kind of stress is crucial for your health and happiness
2
Are Neanderthals descendants of modern humans?
3
We might finally know how to use quantum computers to boost AI
4
Hospital-acquired pneumonia reduced by daily toothbrushing
5
Exclusive report: Inside Chernobyl, 40 years after nuclear disaster
6
Can we ‘vaccinate’ ourselves against stress?
7
Is a super El Niño imminent, and what could the impacts be?
8
Why is it so hard to change your mind?
9
Parrot uses his broken beak to become a dominant male
10
Electric vehicle owners could earn thousands by supporting power grid
